Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 23 THE SOLUBLE GUANYLATE CYCLA...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
23 THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR BAY 60-2770 RESTORES PURINOCEPTOR-INDUCED BLADDER CONTRACTIONS IN A RAT MODEL OF CHRONIC PROSTATITIS

23 THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR BAY 60-2770 RESTORES PURINOCEPTOR-INDUCED BLADDER CONTRACTIONS IN A RAT MODEL OF CHRONIC PROSTATITIS

Bibliographic Details
Main Authors: O Aydogdu, T Carlsson, P Aronsson, M Winder
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Continence
Online Access:http://www.sciencedirect.com/science/article/pii/S2772973722005021
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2772973722005021

Similar Items

  • Treatment with the soluble guanylate cyclase activator BAY 60-2770 restores in vitro bladder contractile responses in a rat model of chronic prostatitis
    by: Ozgu Aydogdu, et al.
    Published: (2022-12-01)
  • 24 SOLUBLE GUANYLATE CYCLASE DEPENDENCY OF AQUEOUS NO FUNCTIONAL RESPONSES IN HEALTHY AND INFLAMED RAT URINARY BLADDER
    by: P Aronsson, et al.
    Published: (2022-06-01)
  • Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide
    by: Patrik Aronsson, et al.
    Published: (2023-09-01)
  • The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
    by: Raymond L. Benza, et al.
    Published: (2024-03-01)
  • Crystal structures of the catalytic domain of human soluble guanylate cyclase
    by: Allerston, C, et al.
    Published: (2013)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs